Bookmark
Forward
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.
American journal of respiratory and critical care medicine 2013 Jun 1Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Daniel M Rose, A Bruce Montgomery. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. American journal of respiratory and critical care medicine. 2013 Jun 1;187(11):1269
Mesh Tags
Substances
PMID: 23725617
View Full Text
